Cigna Investments’s Ginkgo Bioworks DNA Stock Holding History

Cigna Investments’s Portfolio DNA Stock Details DNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-373	Closed	-$18K	–	456
2024 Q1	$18K	Hold	373	–	–	﹤0.01%	459
2023 Q4	$25K	Hold	373	–	–	0.01%	439
2023 Q3	$27K	Hold	373	–	–	0.01%	418
2023 Q2	$28K	Buy	+373	New	+$22.1K	0.01%	455

Other funds holding DNA

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

ACG

Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

GCM

Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return

SIAU

SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Cigna Investments's DNA Position: Q2 2024 in Review

Cigna Investments sold out of Ginkgo Bioworks (DNA) in Q2 2024, closing a stake of 373 shares — an estimated $18K sold.

Cigna Investments first reported a position in DNA in Q2 2023 and held it in 4 quarters. The position peaked at $28K in Q2 2023. 313 funds tracked by Wall St. Rank hold DNA as of Q2 2024.

Cigna Investments reported no remaining Ginkgo Bioworks position as of Q2 2024 after selling out during the quarter.
Cigna Investments sold 373 Ginkgo Bioworks shares in Q2 2024, an estimated $18K.
Cigna Investments first reported a position in Ginkgo Bioworks in Q2 2023 and held it in 4 quarters.
Cigna Investments's Ginkgo Bioworks position peaked at $28K in Q2 2023.
313 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2024.

Based on Cigna Investments's 13F filing for Q2 2024, filed 17 Jul 2024.